![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Dowman Joanna K Holt Andrew P Newsome Philip N Adams David H
Publisher: Informa Healthcare
ISSN: 1472-8214
Source: Expert Opinion on Emerging Drugs, Vol.13, Iss.1, 2008-03, pp. : 159-174
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ropivacaine clearance is reduced in chronic end-stage liver disease
Inpharma, Vol. 1, Iss. 1573, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epidemiology of end-stage renal disease
Clinical Medicine, Vol. 2, Iss. 3, 2002-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)